Related references
Note: Only part of the references are listed.Innate immunity mediates myocardial preconditioning through Toll-like receptor 2 and TIRAP-dependent signaling pathways
Jian-Wen Dong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Myocardial Ischemia/Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti-Toll-Like Receptor-2 Antibody
Fatih Arslan et al.
CIRCULATION (2010)
Preconditioning by toll-like receptor 2 agonist Pam3CSK4 reduces CXCL1-dependent leukocyte recruitment in murine myocardial ischemia/reperfusion injury
Jan Mersmann et al.
CRITICAL CARE MEDICINE (2010)
Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis
Mark Tidswell et al.
CRITICAL CARE MEDICINE (2010)
A Role for Toll-like Receptor 3 Variants in Host Susceptibility to Enteroviral Myocarditis and Dilated Cardiomyopathy
Carlos Gorbea et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Use of Sealants and Buttressing Material in Pulmonary Surgery: An Evidence-Based Approach
Thomas W. Rice et al.
Thoracic Surgery Clinics (2010)
Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart
Wei Chao
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility:: role of Toll-like receptor 9
Pascal Knuefermann et al.
CARDIOVASCULAR RESEARCH (2008)
Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction
Leo Timmers et al.
CIRCULATION RESEARCH (2008)
Local expression of Toll-like receptor 4 at the site of ruptured plaques in patients with acute myocardial infarction
Yuh Ishikawa et al.
CLINICAL SCIENCE (2008)
Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events
Adam E. Mullick et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury
Fang Hua et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity
Hideo Negishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Local overexpression of toll-like receptors at the vessel wall induces atherosclerotic lesion formation - Synergism of TLR2 and TLR4
Masakazu Shinohara et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism
Fang Hua et al.
JOURNAL OF IMMUNOLOGY (2007)
Association between Toll-like receptors and the extent and severity of coronar, artery disease in patients with stable angina
Etsuko Mizoguchi et al.
CORONARY ARTERY DISEASE (2007)
Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury
Yasushi Sakata et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury
Hordur S. Hardarson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Hyaluronan fragments act as an endogenous danger signal by engaging TLR2
Kara A. Scheibner et al.
JOURNAL OF IMMUNOLOGY (2006)
Inhibition of toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury
Akira Shimamoto et al.
CIRCULATION (2006)
Cutting edge: High-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury
Kunihiko Izuishi et al.
JOURNAL OF IMMUNOLOGY (2006)
Modulation of atherosclerosis in mice by Toll-like receptor 2
AE Mullick et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of coxsackievirus B3-induced myocarditis and influences type I interferon production
K Fuse et al.
CIRCULATION (2005)
Expansion of circulating toll-like receptor 4-positive monocytes in patients with acute coronary syndrome
H Methe et al.
CIRCULATION (2005)
Bone marrow-derived cells contribute to contractile dysfunction in endotoxic shock
BW Binck et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Recognition of single-stranded RNA viruses by Toll-like receptor 7
JM Lund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mechanisms of the TRIF-induced interferon-stimulated response element and NF-κB activation and apoptosis pathways
KJ Han et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Targeted anticytokine therapy in patients with chronic heart failure - Results of the Randomized Etanercept Worldwide evALuation (RENEWAL)
DL Mann et al.
CIRCULATION (2004)
Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways
H Björkbacka et al.
NATURE MEDICINE (2004)
Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice
J Oyama et al.
CIRCULATION (2004)
Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices
EJ Birks et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2004)
Toll-like receptor 2 mediates Staphylococcus aureus-induced myocardial dysfunction and cytokine production in the heart
P Knuefermann et al.
CIRCULATION (2004)
Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart
AJ Chong et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2004)
Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E
KS Michelsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study
PE Morange et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2004)
Chlamydia pneumoniae - An infectious risk factor for atherosclerosis?
LA Campbell et al.
NATURE REVIEWS MICROBIOLOGY (2004)
Immune cell toll-like receptor 4 is required for cardiac myocyte impairment during endotoxemia
SA Tavener et al.
CIRCULATION RESEARCH (2004)
The obsession with primary angioplasty
G Melandri
CIRCULATION (2003)
Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction
T Shishido et al.
CIRCULATION (2003)
Association of the toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events
N Ameziane et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis
IA Yang et al.
ATHEROSCLEROSIS (2003)
Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway
M Yamamoto et al.
SCIENCE (2003)
IRAK1 deletion disrupts cardiac Toll/IL-1 signaling and protects against contractile dysfunction
JA Thomas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Expression of Toll-like receptor 4 is associated with enteroviral replication in human myocarditis
M Satoh et al.
CLINICAL SCIENCE (2003)
Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events
SM Boekholdt et al.
CIRCULATION (2003)
IL-12 receptor β1 and Toll-like receptor 4 increase IL-1β- and IL-18-associated myocarditis and Coxsackievirus replication
D Fairweather et al.
JOURNAL OF IMMUNOLOGY (2003)
Stress-activated cytokines and the heart: From adaptation to maladaptation
DL Mann
ANNUAL REVIEW OF PHYSIOLOGY (2003)
Cutting edge:: A novel toll/IL-1 receptor Domain containing adapter that preferentially activates the IFN-β promoter in the toll-like receptor signaling
M Yamamoto et al.
JOURNAL OF IMMUNOLOGY (2002)
Inflammatory mediators and the failing heart - Past, present, and the foreseeable future
DL Mann
CIRCULATION RESEARCH (2002)
CD14-deficient mice are protected against lipopolysaccharide-induced cardiac inflammation and left ventricular dysfunction
P Knuefermann et al.
CIRCULATION (2002)
Toll-like receptor 4 polymorphisms and atherogenesis
S Kiechl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
HSP70 as endogenous stimulus of the toll/interleukin-1 receptor signal pathway
RM Vabulas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Inflammation and atherosclerosis
P Libby et al.
CIRCULATION (2002)
Toll-like receptors and innate immunity
R Medzhitov
NATURE REVIEWS IMMUNOLOGY (2001)
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
L Alexopoulou et al.
NATURE (2001)
Advances in the understanding of myocarditis
PP Liu et al.
CIRCULATION (2001)
Immunopathogenesis of atherosclerosis -: Endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet
HA Lehr et al.
CIRCULATION (2001)
Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the Toll/interleukin-1 receptor signaling pathway in innate immune cells
RM Vabulas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4
G Baumgarten et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Role of TLR-8 in the activation of nuclear factor κB by oxidative stress in cardiac myocytes
S Frantz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A Toll-like receptor recognizes bacterial DNA
H Hemmi et al.
NATURE (2000)